Clinical Trial Update: Evaluating ABRYSVO Maternal Vaccine Effectiveness Among Infants

View source ↗

Summary

Pfizer's ABRYSVO maternal RSV vaccine is listed as active but not recruiting in a trial evaluating infant effectiveness.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• ABRYSVO

Snippet

Sponsor: Pfizer | Conditions: Respiratory Syncytial Virus (RSV) | Status: ACTIVE_NOT_RECRUITING